A possible link between vaccination and the risk of MS has been controversial for some time, however, a growing number of studies are providing high quality evidence to refute this link. MS Research Australia recently reported on a large US study that came to the same conclusion in November last year.
This new study, led by researchers from the Statens Serum Institute in Denmark and the Karolinska Institute in Sweden, provides gold standard evidence from data collected via routine nationwide registers of unselected populations in two countries. The HPV vaccine was licensed in 2006 for wide-scale dissemination to all females to protect against the papillomavirus infection that contributes to the development of cervical cancer.
The authors suggest that there is no evidence for a causal relationship between HPV vaccination and demyelinating disorders, and do not recommend any changes to current vaccination policy.